Product Information
TELMISARTAN-AMLODIPINE 40-5 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $2.8717 per EA under NDC 00378107593. Its NADAC has been published 167 times since Apr 19, 2023.
Strength
5; 40 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378107593
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202516On Market Since
9/19/2014
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN-AMLODIPINE 40-5 MG has been published 167 times since Apr 19, 2023, and over the history we have for it it has declined 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8717 per EA |
|---|---|
| All-time high | $3.8874 (Jun 14, 2023) |
| All-time low | $2.1556 (Jan 22, 2025) |
| 52-week high | $2.8968 |
| 52-week low | $2.5031 |
| Median price | $2.6677 |
| Average price | $2.7111 |
| Largest weekly change | -31.8% (Jun 21, 2023) |
| Weeks tracked | 167 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the telmisartan and amlodipine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TELMISARTAN-AMLODIPINE 40-5 MG?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-AMLODIPINE 40-5 MG, manufactured by Mylan Pharmaceuticals Inc., is $2.8717 per EA (NDC 00378107593), effective Jun 24, 2026.
How has the price of TELMISARTAN-AMLODIPINE 40-5 MG changed over time?
Over the history we have for it, the NADAC for TELMISARTAN-AMLODIPINE 40-5 MG has declined 26.1%. It has been tracked across 167 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for TELMISARTAN-AMLODIPINE 40-5 MG?
Since Apr 19, 2023, the NADAC for TELMISARTAN-AMLODIPINE 40-5 MG has ranged from a low of $2.1556 (Jan 22, 2025) to a high of $3.8874 (Jun 14, 2023), with a median of $2.6677 per EA.
Are there cheaper alternatives to TELMISARTAN-AMLODIPINE 40-5 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TELMISARTAN-AMLODIPINE 40-5 MG, so no direct lower-cost alternative is listed.
Who manufactures TELMISARTAN-AMLODIPINE 40-5 MG?
TELMISARTAN-AMLODIPINE 40-5 MG (NDC 00378107593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification